logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9066901 B1

PDFFull Text
Date of Patent:
Jun. 30, 2015

Filed:

Jul. 12, 2012

C-met receptor regulation by angiotensin iv (at4) receptor ligands

Applicants:

Joseph W. Harding, Pullman, WA (US);

John W. Wright, Pullman, WA (US);

Patrick D. Elias, Pullman, WA (US);

Brent J. Yamamoto, Pullman, WA (US);

Leen H. Kawas, Pullman, WA (US);

Inventors:

Joseph W. Harding, Pullman, WA (US);

John W. Wright, Pullman, WA (US);

Patrick D. Elias, Pullman, WA (US);

Brent J. Yamamoto, Pullman, WA (US);

Leen H. Kawas, Pullman, WA (US);

Assignee:

Washington State University, Pullman, WA (US);

Attorney:

Whitham Curtis Christofferson & Cook, PC

Primary Examiner:

James H Alstrum Acevedo

Assistant Examiner:

Zachary J Miknis

Int. Cl.
CPC ...
A61K 38/22 (2006.01); C07K 14/475 (2006.01); A61K 38/00 (2006.01); A61P 3/04 (2006.01); A61P 25/00 (2006.01); C07K 14/47 (2006.01); A61K 38/08 (2006.01); A61K 38/18 (2006.01); C07K 14/705 (2006.01); C07K 5/087 (2006.01); C07K 5/09 (2006.01); C07K 5/093 (2006.01); C07K 5/103 (2006.01); C07K 5/11 (2006.01); C07K 5/113 (2006.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01); C07K 5/107 (2006.01); C07K 5/083 (2006.01); C07K 5/065 (2006.01); C07K 5/072 (2006.01); C07K 5/062 (2006.01); C07K 5/068 (2006.01);
U.S. Cl.
CPC ...
A61K 38/085 (2013.01); A61K 38/1833 (2013.01); C07K 14/705 (2013.01); C07K 5/0812 (2013.01); C07K 5/0815 (2013.01); C07K 5/0819 (2013.01); C07K 5/101 (2013.01); C07K 5/1019 (2013.01); C07K 5/1021 (2013.01); G01N 33/502 (2013.01); G01N 33/5023 (2013.01); G01N 33/6893 (2013.01); G01N 2800/044 (2013.01); C07K 5/0817 (2013.01); C07K 5/1016 (2013.01); C07K 5/0808 (2013.01); C07K 5/06078 (2013.01); C07K 5/06095 (2013.01); C07K 5/06034 (2013.01); C07K 5/06086 (2013.01); C07K 5/06113 (2013.01);
Abstract

Angiotensin-like factor compositions and methods for using them to diagnose, prevent and/or treat conditions associated with c-Met dysregulation, are provided. The conditions include cancer, obesity, conditions associated with obesity, and neurodegenerative diseases such as general dementia, Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis, traumatic brain injury and spinal cord trauma.

Find Patent Forward Citations

Loading…